Terms: = Uterine cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C
29 results:
1. Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct.
Grizzi F; Chiriva-Internati M; Miranda E; Zaharie R; Hajjar NA; Zaharie F; Del Arco CD; Fernández-Aceñero MJ; Bresalier RS; Moiş E
Pathol Res Pract; 2023 Jul; 247():154546. PubMed ID: 37224658
[TBL] [Abstract] [Full Text] [Related]
2. Deletion of the tyrosine phosphatase shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism.
Gao X; Kang J; Li X; Chen C; Luo D
FASEB J; 2023 Apr; 37(4):e22880. PubMed ID: 36943407
[TBL] [Abstract] [Full Text] [Related]
3. Cervical neoplasia in relation to socioeconomic and demographic factors - a nationwide cohort study (2002-2018).
Jansåker F; Li X; Sundqvist A; Sundquist K; Borgfeldt C
Acta Obstet Gynecol Scand; 2023 Jan; 102(1):114-121. PubMed ID: 36330802
[TBL] [Abstract] [Full Text] [Related]
4. Structure-based discovery of a specific shp2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
Ma Y; Li WY; Sun T; Zhang L; Lu XH; Yang B; Wang RL
Bioorg Chem; 2022 Apr; 121():105648. PubMed ID: 35180489
[TBL] [Abstract] [Full Text] [Related]
5. Synergistic Cytotoxicity Effect of 5-Fluorouracil and shp2 Inhibitor Demethylincisterol A3 on Cervical cancer Cell.
Liu Y; Fu H; Zuo L
Anticancer Agents Med Chem; 2022; 22(7):1313-1319. PubMed ID: 34238199
[TBL] [Abstract] [Full Text] [Related]
6. Demonstrating the effect of shp2 inhibitor on cervical squamous cell carcinoma from the perspective of ZAP70.
Gong M; Liu P; He T; Zhang M; Li G
Anticancer Drugs; 2021 Jun; 32(5):477-483. PubMed ID: 33661186
[TBL] [Abstract] [Full Text] [Related]
7. shp2 expression is upregulated in cervical cancer, and shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.
Cao M; Gao D; Zhang N; Duan Y; Wang Y; Mujtaba H; Wang Y
Pathol Res Pract; 2019 Nov; 215(11):152621. PubMed ID: 31564571
[TBL] [Abstract] [Full Text] [Related]
8. Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
9. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.
Shao H; Ma L; Jin F; Zhou Y; Tao M; Teng Y
Biochem Biophys Res Commun; 2018 Nov; 506(1):243-250. PubMed ID: 30343889
[TBL] [Abstract] [Full Text] [Related]
10. LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical cancer in a Chinese Population.
Wang Y; Luo T
Cancer Control; 2018; 25(1):1073274818803942. PubMed ID: 30286619
[TBL] [Abstract] [Full Text] [Related]
11. High Prevalence of
Seo SS; Arokiyaraj S; Kim MK; Oh HY; Kwon M; Kong JS; Shin MK; Yu YL; Lee JK
Biomed Res Int; 2017; 2017():5435089. PubMed ID: 29479540
[No Abstract] [Full Text] [Related]
12. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
[TBL] [Abstract] [Full Text] [Related]
13. PIAS3, shp2 and SOCS3 Expression patterns in Cervical cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract] [Full Text] [Related]
14. Gamma tocotrienol targets tyrosine phosphatase shp2 in mammospheres resulting in cell death through RAS/ERK pathway.
Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.
Li J; Bonifati S; Hristov G; Marttila T; Valmary-Degano S; Stanzel S; Schnölzer M; Mougin C; Aprahamian M; Grekova SP; Raykov Z; Rommelaere J; Marchini A
EMBO Mol Med; 2013 Oct; 5(10):1537-55. PubMed ID: 24092664
[TBL] [Abstract] [Full Text] [Related]
16. shp-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production.
Meng F; Zhao X; Zhang S
J Obstet Gynaecol Res; 2013 Jan; 39(1):272-9. PubMed ID: 22889324
[TBL] [Abstract] [Full Text] [Related]
17. Expression and significance of shp-2 in human papillomavirus infected cervical cancer.
Meng F; Zhao X; Zhang S
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):247-251. PubMed ID: 22528229
[TBL] [Abstract] [Full Text] [Related]
18. Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study.
Necchi V; Sommi P; Vanoli A; Manca R; Ricci V; Solcia E
PLoS One; 2011; 6(6):e21317. PubMed ID: 21695063
[TBL] [Abstract] [Full Text] [Related]
19. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract] [Full Text] [Related]
20. Significance of SHP-1 and shp-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.
Tao XH; Shen JG; Pan WL; Dong YE; Meng Q; Honn KV; Jin R
Pathol Oncol Res; 2008 Dec; 14(4):365-71. PubMed ID: 18543080
[TBL] [Abstract] [Full Text] [Related]
[Next]
